Loading company…
Riskpilot
← Back to search
Sign in
Get full access
EE Farmaci AB
AB
Active
Org 5591579577
Stålhamravägen 47
Temporary employment agency activities and other human resource provisions · NACE 7820
Est. 2018
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 407K
-46% vs 2024
EBITDA margin
65.5%
-18% vs 2024
Equity ratio
99.4%
Financial strength
Net profit 2025
SEK 228K
-12% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 407K
-46%
EBITDA
SEK 267K
-18%
Net profit
SEK 228K
-12%
Total assets
SEK 967K
-2%
Equity
SEK 961K
+2%
Employees
1
—
Company information
Legal name
EE Farmaci AB
Org number
5591579577
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
4 maj 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolag skall bedriva uthyrning av apotekspersonal, äga och förvalta värdepapper samt därmed förenlig verksamhet.
Contact
Address
Stålhamravägen 47
Email
majd.ishak@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Temporary employment agency activities and other human resource provisions
Companies in Södertälje
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
692
771
621
752
407
Staff expenses
—
−197
−486
−332
−99
EBITDA
498
466
20
325
267
Depreciation & amort.
−0
—
—
—
—
EBIT
498
466
20
325
267
Net financials
—
—
−1
0
16
Profit before tax
498
466
19
325
283
Tax
−107
−96
−4
−67
−55
Net profit
391
370
14
258
228
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 165
1 367
1 014
989
967
Equity
1 028
1 148
937
941
961
Long-term debt
0
—
—
—
—
Short-term debt
137
219
77
48
6
Total debt
137
219
77
48
6
Financial ratios
5-year trend
EBITDA margin
65.5%
This company
15.8%
Market median
+315% vs market
2021
2025
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
2021
2025
Return on equity
23.7%
This company
18.4%
Market median
+29% vs market
2021
2025
Net profit margin
56.0%
This company
8.1%
Market median
+591% vs market
2021
2025
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
2021
2025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
ZI
Zaid Imad Ishak
Deputy Board Member
2022
MI
Majd Imad Ishak
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of EE Farmaci AB also hold positions in
0
other companies.
Person
Role here
Other companies
Zaid Imad Ishak
Deputy Board Member
0 companies
Majd Imad Ishak
Board of Directors
0 companies